Journals listed in Web of Science and JCR receive many submissions and desk reject a large share. A section-by-section audit by a PhD reviewer in your area shows what to fix first.
Manuscript Auditing →01Impact factor
Impact factor of NeuroImmunoModulation (2026)
The impact factor shown here is the 2-year mean citedness: citations received in a year by the papers NeuroImmunoModulation published in the two previous years, divided by the number of those papers. That is the same formula as the Journal Impact Factor, calculated by ScholarsColab. The journal is listed in JCR 2024, so it also has an official Journal Impact Factor published by Clarivate, which can differ because it counts citations from Web of Science journals only.
Rank in its subject categories
- Endocrinology & Metabolismrank 137 of 203 journals
- Immunologyrank 128 of 189 journals
- Neurosciencesrank 223 of 321 journals
Ranks here compare journals of the same Web of Science category in our data by 2-year citedness; they are not the official JCR rank.
Quartile of NeuroImmunoModulation
A journal's quartile (Q1 to Q4) is its position within a subject category: Q1 is the top quarter. The official quartiles are published by Clarivate in Journal Citation Reports (by Journal Impact Factor, in Web of Science categories) and by Scimago as the SJR quartile (in Scopus categories). NeuroImmunoModulation is listed in JCR 2024, so its JCR quartile is in Journal Citation Reports. It is indexed in Scopus, so Scimago shows its SJR quartile. ScholarsColab does not show a quartile until it can show the official one; the impact factor and rank above are calculated from open data.
Citations and papers per year
Open access (listed in DOAJ).
Is your paper a fit for NeuroImmunoModulation?
Most desk rejections come from a scope mismatch. Compare your title and abstract with what this journal really publishes. Free, no sign-up, about 2 minutes.
Check my paper for this journalOr find journals that fit my paper
02Fee waivers
APC waivers and discounts for NeuroImmunoModulation
NeuroImmunoModulation follows the waiver policy of its publisher, Karger: waiver or discount for low and lower-middle income countries; percentages are not published. Only the corresponding author's affiliation counts. Co-authors from other countries do not change the waiver.
Waivers apply to fully open access journals. If NeuroImmunoModulation is a hybrid journal, you can publish without any fee through the subscription route.
Checking the waiver rules for your country…
Retractions and research integrity at NeuroImmunoModulation
Retractions per year
Most common reasons (a retraction can have several):
NeuroImmunoModulation has 6 retracted papers on record, the latest in Jun 2024. A retraction count is not a verdict on a journal: large journals publish more and journals that investigate actively retract more. The trend and the reasons tell you more than the number. Retractions for paper mills or compromised peer review usually come in batches after an investigation; check whether they are recent before you decide.
Who funds research published in NeuroImmunoModulation
A high share of funded papers usually means the journal is a common choice for grant-supported work in its field. If your funder pays article processing charges, or your country qualifies for a waiver, check what applies to your author team with the free APC waiver checker.
03Indexing
Indexing of NeuroImmunoModulation
- ISSN
- 1021-7401
- eISSN
- 1423-0216
- Publisher
- Karger Publishers all its journals →
- Subjects
- Endocrinology & Metabolism, Immunology, Neurosciences
From the indexing lists used on ScholarsColab, updated 1 March 2026. Indexing can change: confirm on the Web of Science Master Journal List or the Scopus source list before submitting. Official Journal Impact Factors and JCR quartiles are published by Clarivate; the impact factor on this page is calculated by ScholarsColab (see how the impact factor works).
- Web of Science Master Journal List
- SCImago Journal Rank
- ISSN Portal (ISSN 1021-7401)
- DOAJ (Directory of Open Access Journals)
Each link opens the official record for this journal, searched by its ISSN where we have one.
04How to submit
How to submit to NeuroImmunoModulation
- Read the guide for authors. It sets the article types, word limit, reference style and file format that NeuroImmunoModulation accepts. You find it on the official website of the journal, usually under "For authors" or "Submit".
- Format to the journal's style. Check whether it wants a Word file, a LaTeX file or a PDF for the first submission, and follow its reference style; many journals accept any clear format at first and ask for their style only after acceptance.
- Check the fit. Read the aims and scope and a few recent issues; papers outside the scope are the most common reason for a desk rejection. The Journal Finder shows journals that published the closest work.
- Plan the fee. NeuroImmunoModulation is fully open access and lists no article fee in DOAJ. See whether your author team qualifies for a waiver with the free APC waiver checker.
- Check your manuscript before you submit. The free Submission Readiness Check asks the seven questions our reviewers ask in every audit and takes about 2 minutes.
05Reviewer comments
Reviewer comments and rejection reasons for NeuroImmunoModulation
No reviewer or editor comments have been shared for this journal yet. Did you submit here? Help other researchers by sharing the comments you received, anonymously.
Share reviewer comments for this journal →Planning to submit to NeuroImmunoModulation? A Manuscript Audit by a PhD reviewer in your area checks your paper for the issues reviewers raise most often.
Audit my paper before I submit →Not sure yet? Check if your paper is ready for this journal: free, no AI, under 5 seconds06Same subject
Endocrinology & Metabolism journals with a similar impact factor*
The journals next to NeuroImmunoModulation when the 193 journals of Endocrinology & Metabolism in our data are ranked by impact factor*:
| Rank | Journal | Impact factor* | Indexing | Open access |
|---|---|---|---|---|
| 133 | Comprehensive Psychoneuroendocrinology | 2.12 | ESCI | Fully open access |
| 134 | Neuroendocrinology | 2.10 | SCIE | Subscription |
| 135 | Annals of Pediatric Endocrinology & Metabolism | 2.07 | ESCI | Fully open access |
| 136 | Journal of Clinical Research in Pediatric Endocrinology | 2.04 | SCIE | Fully open access |
| 138 | Osteoporosis and Sarcopenia | 2.01 | ESCI | Fully open access |
| 139 | Diabetology International | 2.00 | ESCI | Subscription |
| 140 | AACE Clinical Case Reports | 1.99 | ESCI | Some open access |
| 141 | International Journal of Endocrinology | 1.97 | SCIE | Fully open access |
*Impact factor calculated by ScholarsColab (2-year citedness), not the official Clarivate value.
Is NeuroImmunoModulation right for your paper? Find the right journal
Paste your title, keywords or abstract. See the journals that published the closest papers, with indexing, impact factor, review time and APC.
No AI or language model is used. Your words are matched against the titles of 156,724 real published journal papers, by our mentors and by other researchers (shown without names); journals are ranked by how many closely matching papers they published. Indexing comes from the SCIE, SSCI, AHCI, ESCI, Scopus and JCR 2024 lists, matched by journal name; the impact factor is calculated by ScholarsColab, not the official Clarivate value, and no quartile is shown until the official JCR or SJR quartile can be; review time is the median days from submission to acceptance (not every publisher publishes these dates). Always check a journal’s scope and current indexing before submitting.
07Questions
Frequently asked questions
What is the impact factor of NeuroImmunoModulation?
Based on ScholarsColab citation data (October 2026), the 2-year impact factor of NeuroImmunoModulation is 2.01: papers it published in the two previous years were cited 2.01 times on average in a year. The journal is listed in JCR 2024, so Clarivate also publishes an official Journal Impact Factor, which can differ.
What is the h-index of NeuroImmunoModulation?
The h-index of NeuroImmunoModulation is 87 (October 2026): 87 of its papers have each been cited at least 87 times. Its i10-index is 890.
What is the quartile of NeuroImmunoModulation?
A journal's quartile (Q1 to Q4) is its position within a subject category: Q1 is the top quarter. The official quartiles are published by Clarivate in Journal Citation Reports (by Journal Impact Factor, in Web of Science categories) and by Scimago as the SJR quartile (in Scopus categories). NeuroImmunoModulation is listed in JCR 2024, so its JCR quartile is in Journal Citation Reports. It is indexed in Scopus, so Scimago shows its SJR quartile. ScholarsColab does not show a quartile until it can show the official one; the impact factor and rank above are calculated from open data.
Is NeuroImmunoModulation indexed in Scopus?
Yes. NeuroImmunoModulation appears in the Scopus list, according to the indexing lists used on ScholarsColab (updated 1 March 2026). Always confirm the current status on the official list before submitting.
Is NeuroImmunoModulation an SCIE journal?
Yes. NeuroImmunoModulation is listed in the Science Citation Index Expanded (SCIE), according to the indexing lists used on ScholarsColab (updated 1 March 2026). Always confirm the current status on the official list before submitting.
Is NeuroImmunoModulation in Journal Citation Reports (JCR)?
Yes. NeuroImmunoModulation is listed in JCR 2024, so it has a Journal Impact Factor. For the current impact factor and quartile, check Journal Citation Reports.
Does NeuroImmunoModulation offer an APC waiver?
NeuroImmunoModulation follows the policy of Karger: waiver or discount for low and lower-middle income countries; percentages are not published. Only the corresponding author's affiliation counts. Co-authors from other countries do not change the waiver. Rules verified 27 October 2026; confirm on the publisher's page.
Has NeuroImmunoModulation retracted papers?
Yes. 6 retracted papers are on record for NeuroImmunoModulation, 6 of them in the last 10 years; the most common reasons are concerns/issues about data, concerns/issues about authorship/affiliation, duplication of/in image. A retraction count alone is not a verdict on a journal; look at the trend and the reasons. Data updated October 2026.
Who funds research published in NeuroImmunoModulation?
0% of 69 recent research articles in NeuroImmunoModulation name a funder.
Popular journals
- The Lancet
- Nature
- Science
- PLoS ONE
- Scientific Reports
- Journal of the American Chemical Society
- Analytica Chimica Acta
- Journal of Physical Chemistry B
- IEEE Transactions on Magnetics
- Journal of Applied Physics
- Applied Optics
- Physics Today
- Journal of Applied Polymer Science
- Thin Solid Films
- Ceramics International
- Journal of Physical Chemistry
- Energies
- BMJ
- Electronics Letters
- Gastroenterology
Browse all journals: indexing, impact factor and reviewer comments →